Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.

[1]  Justin B Dimick,et al.  Variation in hospital mortality associated with inpatient surgery. , 2009, The New England journal of medicine.

[2]  L. Horn,et al.  Characteristics and Management of Diaphragm Involvement in Patients With Primary Advanced-Stage Ovarian, Fallopian Tube, or Peritoneal Cancer , 2009, International Journal of Gynecologic Cancer.

[3]  E. Darai,et al.  Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer , 2009, BJOG : an international journal of obstetrics and gynaecology.

[4]  Jacobus Pfisterer,et al.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.

[5]  G. Kenter,et al.  EORTC-GcG/NCIC-CTG Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA) , 2008 .

[6]  W. Cliby,et al.  Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. , 2008, Gynecologic oncology.

[7]  P. Neven,et al.  Role of diaphragmatic surgery in 69 patients with ovarian carcinoma , 2007, International Journal of Gynecologic Cancer.

[8]  D. Levine,et al.  What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? , 2007, Gynecologic oncology.

[9]  R. Barakat,et al.  Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. , 2006, Gynecologic oncology.

[10]  W. Cliby,et al.  Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. , 2006, Gynecologic oncology.

[11]  Jeong-Won Lee,et al.  Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery , 2006, The journal of obstetrics and gynaecology research.

[12]  Pascale Carayon,et al.  A human factors engineering conceptual framework of nursing workload and patient safety in intensive care units. , 2005, Intensive & critical care nursing.

[13]  M. Berman.  Future directions in the surgical management of ovarian cancer. , 2003, Gynecologic oncology.

[14]  K. Tewari,et al.  Unusual presentation of a malignant granular cell tumor of the pelvis: case report and literature review. , 2003, Gynecologic oncology.

[15]  A. Covens.  A critique of surgical cytoreduction in advanced ovarian cancer. , 2000, Gynecologic oncology.

[16]  C. Griffiths,et al.  Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. , 1990, Gynecologic oncology.

[17]  J. Berek,et al.  Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer , 1990 .

[18]  M. Deppe,et al.  Surgical approach to diaphragmatic metastases from ovarian cancer. , 1986, Gynecologic oncology.

[19]  P. Lumbiganon,et al.  Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. , 2009, Gynecologic oncology.

[20]  L. Shulman.  Aggressive surgical strategies in advanced ovarian cancer: A monocentric study of 203 stage IIIC and IV patients , 2009 .

[21]  D. Atallah,et al.  Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  E. Trimble,et al.  Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.